Streptomyces pluricolorescens Okami and Umezawa (ATCC® 19798)

Strain Designations: ISP 5019 [91-T1-1, CBS 550.68, IFO 12808, NIHJ 238, RIA 1077]  /  Type Strain: yes  /  Biosafety Level: 1

Strain Designations ISP 5019 [91-T1-1, CBS 550.68, IFO 12808, NIHJ 238, RIA 1077]
Application
Produces pluramycin
Production of pluramycin A and B
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain yes (type strain)
Comments
Streptomyces anulatus
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor EB Shirling
Chain of Custody
ATCC <<--EB Shirling<<--Y. Okami NIHJ 238
References

. . Bergey's Manual Syst. Bacteriol. 4: 2471, 1989.

Maeda K, et al. A new antitumor substance pluramycin. Studies on antitumor substances produced by actinomycetes. J. Antibiot. Ser. A 9: 75-80, 1956.

Shirling EB, Gottlieb D. Cooperative description of type cultures of Streptomyces. II. Species descriptions from first study. Int J Syst Bacteriol 18: 69-189, 1968.

Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.

. The Actinomycetes. 2Baltimore: Williams & Wilkins; 1961.

type strain

type strain